Drug-drug interactions in myocardial infarction Patients and their risk factors

Authors

  • T.Rushinaidu Assistant Professor in Avanthi Institute of Pharmaceutical sciences, Cherukupalli, Vizianagram
  • P.Prasanna Student of Avanthi Institute of Pharmaceutical Sciences, Cherukupalli, Vizianagram
  • A.Susmita Student of Avanthi Institute of Pharmaceutical Sciences, Cherukupalli, Vizianagram
  • K.Anusha Student of Avanthi Institute of Pharmaceutical Sciences, Cherukupalli, Vizianagram

DOI:

https://doi.org/10.47957/ijpda.v10i1.490

Keywords:

Myocardial infarction, Drug interactions, Risk factors, effects

Abstract

AIM: To study drug-drug interactions in myocardial infarction patients.

METHODOLOGY: A prospective interventional study was done on myocardial infarction with drug interactions patients admitted in tertiary government and corporate hospital, Visakhapatnam Andhra Pradesh, India. Information regarding the gender, risk factors, type of drug interactions as major, moderate, minor were recorded in a standard questionnaire (case report form).RESULTS: A total of 100 cases were included after excluding missing data. Out of 100 cases,62 were male and 38 were female.Myocardial infarction in patients in which we assessed risk factors among them were HTN-67%,previous history of CVD-66%,family history-60%,Hyperlipidemia-40%,Diabetes milletus-38%,smoking-64%,Drug interactions were Major,Moderate,Minor.Major interactions were 24, Moderate interactions were 318, Minor interactions were 91.CONCLUSION: Based on the above data risk factors mostly seen in HTN and previous history of CVD, drug interactions mostly observed were moderate drug interactions.

Downloads

Download data is not yet available.

References

Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015. JAMA. 2017;317(2):165–82.

PubMed

Published

2022-01-20
Statistics
672 Views | 329 Downloads
Citatons

How to Cite

T, R., P. P, S. A, and A. K. “Drug-Drug Interactions in Myocardial Infarction Patients and Their Risk Factors”. International Journal of Pharmaceutics and Drug Analysis, vol. 10, no. 1, Jan. 2022, pp. 01-05, doi:10.47957/ijpda.v10i1.490.

Issue

Section

Research Articles
Share |